Meteneprost

Meteneprost is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 163 references associated with Meteneprost in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

All references with Meteneprost

Download all related citations
Per page 10 20 50 | Total 43
Authors Title Published Journal PubMed Link
A multicentre randomized comparative clinical trial of 200 mg RU486 (mifepristone) single dose followed by either 5 mg 9-methylene PGE(2) gel (meteneprost) or 600 microg oral PGE(1) (misoprostol) for termination of early pregnancy within 28 days of missed menstrual period. ICMR Task Force Study. Indian Council of Medical Research. 2000 Contraception pmid:11124359
Takkar D et al. Early abortion by mifepristone (RU 486) followed by vaginal gel (meteneprost) versus oral (misoprostol) prostaglandin. 1999 Adv Contracept pmid:10997897
A multicentre clinical trial with RU 486 followed by 9-methylene-PGE2 vaginal gel for termination of early pregnancy: a dose-finding study. Indian Council of Medical Research Task Force on Hormonal Contraception. 1994 Contraception pmid:8137628
Gottlieb C and Bygdeman M The use of antiprogestin (RU 486) for termination of second trimester pregnancy. 1991 Acta Obstet Gynecol Scand pmid:1927296
Gottlieb C et al. Vacuum aspiration for termination of early second trimester pregnancy after treatment with vaginal prostaglandin. 1991 Acta Obstet Gynecol Scand pmid:1858494
Maria B et al. Termination of early pregnancy through a combination of the antiprogestin and prostaglandin analogue. 1990 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:2376278
Swahn ML et al. Oral administration of RU 486 and 9-methylene PGE2 for termination of early pregnancy. 1990 Contraception pmid:2347194
Bergren MS et al. Investigation of the relationship between melting-related parameters and in vitro drug release from vaginal suppositories. 1989 J Pharm Biomed Anal pmid:2490759
Hald F et al. Prostaglandin vaginal suppositories in non pregnant women requiring cervical dilatation prior to hysteroscopy. 1988 Acta Obstet Gynecol Scand pmid:3051874
Gréen K et al. Development of a vaginal gel containing 9-deoxo-16,16-dimethyl-9-methylene PGE2 for cervical dilatation and pregnancy termination. 1988 Prostaglandins Leukot. Essent. Fatty Acids pmid:3174718

Table of Content